Biotek-snakken — Januar 2024
-
Top Picks: Two smaller adjustments before the earnings season
... Increasing in Calliditas (from 3.3% of the portfolio to 7%) ...
https://www.redeye.se/research/972048/top-picks-two-smaller-adjustments-before-the-earnings-season
-
Lidt nyt fra Ascelia Pharma. 24 Jan. https://www.ascelia.com/mfn_news/orviglance-review-article-published-in-investigative-radiology/
-
Video - Steg 220% på kun 3 dage - og jeg har aktien (Evaxion)!
https://www.proinvestor.com/boards/118268 -
Calliditas: Vera Therapeutics has released interesting additional 2b results
-
"Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories."
-
-
PS: De er ved at afslutte et fase II-forsøg og har en aftale med FDA om et møde for opsætning af fase III-forsøg https://irlab.se/newsroom/pressrelease-archive/, men det i sig selv er vel ikke tilstrækkeligt til så stor en stigning?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind